Medical devices, healthcare technology and the business of care
510(k) clearance · K262397

CuratOR EX2742

Eizo Corporation · Decision date Sep 11, 2026

MEDTECHLEDGER EXPLANATIONK262397

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for CuratOR EX2742, submitted by Eizo Corporation of Hakusan, Ishikawa, Japan, under 510(k) number K262397. The decision date is 2026-09-11; the application was received 07/14/2026. The record lists the device classification name as Laparoscope, General & Plastic Surgery, regulation number 876.1500, product code GCJ, and regulation medical specialty Gastroenterology/Urology, with review by the General & Plastic Surgery panel.

SESE in the 510(k) pathway denotes clearance to market, not premarket approval. The record describes the submission as a Traditional 510(k), not reviewed by a third party, not a combination product, and without an authorized Predetermined Change Control Plan. The public page does not identify the specific components, accessories or changed items covered, and no summary statement is present in the supplied data, so the scope of the clearance beyond the named device remains unknown.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Gastroenterology, Urology
Decision date
Sep 11, 2026
FDA decision documents: 510(k) Premarket Notification - FDA

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262397
Regulatory pathway
510(k) premarket notification
Product code
GCJ
Decision code
SESE
Decision date
Sep 11, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Laparoscope, General & Plastic Surgery.

Product code
GCJ
FDA device class
2

FDA decision timeline

  1. K262397 received

    Application receipt date recorded by FDA.

  2. K262397 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code GCJ

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Eizo Corporation

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Hakusan, Ishikawa

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records